FERTILITY ENHANCEMENT PREPARATIONS VETERINARY
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| CUE-MATE | VETOQUINOL U.S.A. INC. | 4250 N. SYLVANIA AVE, FORT WORTH TX 76137 | Fertility enhancement preparations for veterinary use, namely, synthetic progesterone contained within pre-filled temporary fertility implants, including such goods sold as a unit with intra-vaginal implant placement devices;Veterinary apparatus, namely, flexible carrier device for use in the intra-vaginal delivery of fertility enhancement preparations sold separately; |
| CUE-MATE | BIONICHE ANIMAL HEALTH USA, INC. | c/o 231 Dundas Street East Belleville, Ontario K8N1E2 Canada | Fertility enhancement preparations for veterinary use, namely, synthetic progesterone contained within pre-filled temporary fertility implants, including such goods sold as a unit with intravaginal implant placement devices;Veterinary apparatus, namely, flexible carrier device for use in the intra-vaginal delivery of fertility enhancement preparations sold separately; |
Where the owner name is not linked, that owner no longer owns the brand |
Technical Examples
- Disclosed herein are novel nucleic acid and protein sequences that are essential to fertility. In particular, human Mater cDNA and protein sequences are provided. Functional MATER is required for female fertility; zygotes that arise from Mater null oocytes do not progress beyond the two-cell stage. Methods are described for using Mater molecules in diagnoses, prognosis, and treatment of infertility and reduced fertility. Also provided are methods for using MATER as a contraceptive agent. The disclosure also describes compounds involved in such methods, and the identification of such compounds.